腾讯网23 天
近1亿美元助力突破RNAi疗法大脑递送瓶颈；潜在“first-in-class”抑郁症 ...
Atalanta Therapeutics的di-siRNA设计改善在大脑中的药物分布 ... initiation-phase-3 [2] Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop ...